KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Current Deferred Revenue (2019 - 2025)

Historic Current Deferred Revenue for Teladoc Health (TDOC) over the last 7 years, with Q3 2025 value amounting to $81.4 million.

  • Teladoc Health's Current Deferred Revenue fell 1765.69% to $81.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.4 million, marking a year-over-year decrease of 1765.69%. This contributed to the annual value of $89.1 million for FY2024, which is 1848.43% down from last year.
  • According to the latest figures from Q3 2025, Teladoc Health's Current Deferred Revenue is $81.4 million, which was down 1765.69% from $85.4 million recorded in Q2 2025.
  • Teladoc Health's 5-year Current Deferred Revenue high stood at $121.6 million for Q2 2023, and its period low was $70.5 million during Q1 2021.
  • For the 5-year period, Teladoc Health's Current Deferred Revenue averaged around $95.3 million, with its median value being $93.4 million (2022).
  • In the last 5 years, Teladoc Health's Current Deferred Revenue soared by 8614.42% in 2021 and then plummeted by 2757.61% in 2025.
  • Over the past 5 years, Teladoc Health's Current Deferred Revenue (Quarter) stood at $102.0 million in 2021, then increased by 11.55% to $113.8 million in 2022, then dropped by 3.96% to $109.3 million in 2023, then decreased by 18.48% to $89.1 million in 2024, then dropped by 8.68% to $81.4 million in 2025.
  • Its Current Deferred Revenue stands at $81.4 million for Q3 2025, versus $85.4 million for Q2 2025 and $84.2 million for Q1 2025.